AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7817684
Drug: KH 1060
RxNorm normalized name: KH-176
DrugBank: Sonlicromanol (DB16333)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KH 1060 ointment 1 microgram/g
Trial: 7817684
Drug: KH 1060
RxNorm normalized name: KH-176
DrugBank: Sonlicromanol (DB16333)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KH 1060 ointment 0.04 microgram/g
Trial: 20816031
Drug: Second-generation antipsychotics
RxNorm normalized name: regenerated cellulose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second-generation antipsychotics (4 types)
Trial: 9418687
Drug: Finasteride (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finasteride (5 mg)
Trial: 18639298
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of doxazosin (4 to 8 mg) and finasteride (5 mg)
Trial: 17054068
Drug: Recombinant vaccine
RxNorm normalized name: CHO Cells Recombinant Vaccine
DrugBank: CHO Cells Recombinant Vaccine (DB15893)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant vaccine (rHAO) 45 microg
Trial: 17054068
Drug: Recombinant vaccine
RxNorm normalized name: CHO Cells Recombinant Vaccine
DrugBank: CHO Cells Recombinant Vaccine (DB15893)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant vaccine (rHAO) 135 microg
Trial: 17054068
Drug: Commercial trivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commercial trivalent influenza vaccine (TIV)
Trial: 2239779
Drug: Continuous intragastric
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intragastric glucose infusion (COG)
Trial: 25566971
Drug: Emotional strategies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emotional strategies employed by staff when notifying patients about treatment allocation.
Trial: 23416808
Drug: No regional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No regional block administered (Control)
Trial: 17280633
Drug: Glucosamine sulphate
RxNorm normalized name: Glucosamine Sulfate 750 MG Oral Capsule [GLUCOSAMINE SULPHATE]
DrugBank: Glucosamine (DB01296)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glucosamine sulphate (1500 mg per day)
Trial: 11240976
Drug: Mibefradil (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mibefradil (100 mg)
Trial: 8923781
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation (66 mg ferrous iron daily)
Trial: 2573240
Drug: Melperone (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melperone (300 mg daily)
Trial: 2479227
Drug: Thiothixene (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiothixene (30 mg daily)
Trial: 1098177
Drug: Bismuth-protein complex
RxNorm normalized name: zinc protein complex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bismuth-protein complex (Bicitropeptide, BCP-Compound)
Trial: 25527736
Drug: Cocoa extract
RxNorm normalized name: Cocoa extract
DrugBank: Cocoa (DB10977)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocoa extract (1.4 g/day)
Trial: 25527736
Drug: Cocoa extract
RxNorm normalized name: Cocoa extract
DrugBank: Cocoa (DB10977)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocoa extract (1.4 g/day) and Control meals
Trial: 21690465
Drug: Regular completion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular completion of European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire‐Core 30 and Hospital Anxiety and Depression Scale with feedback to oncologists
Trial: 16684940
Drug: Trauma-focused cognitive-behavior
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trauma-focused cognitive-behavior treatment (CBT)
Trial: 10659875
Drug: Zidovudine, 160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zidovudine, 160 mg/m2 3 times per day plus lamivudine, 4 mg/kg 2 times per day
Trial: 10659875
Drug: Ritonavir, 350
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir, 350 mg/m2 2 times per day plus zidovudine and lamivudine
Trial: 10659875
Drug: Ritonavir, 350
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir, 350 mg/m2 2 times per day plus stavudine, 4 mg/kg 2 times per day
Trial: 9231929
Drug: Nicotinamide alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotinamide alone (80 mg kg(‐1) daily) with 52.5 Gy in 20 fractions over 4 weeks
Trial: 4063284
Drug: Guar gum
RxNorm normalized name: Guar Gum
DrugBank: Guar gum (DB13446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guar gum (5 or 6 g) with carbohydrate meal (80 ml Hycal)
Trial: 4063284
Drug: Guar gum
RxNorm normalized name: Guar Gum
DrugBank: Guar gum (DB13446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guar gum (5 or 6 g) with protein meal (150 g cooked lean minced beef)
Trial: 4063284
Drug: Guar gum
RxNorm normalized name: Guar Gum
DrugBank: Guar gum (DB13446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guar gum (5 or 6 g) with fat meal (200 ml double cream)
Trial: 4063284
Drug: Guar gum
RxNorm normalized name: Guar Gum
DrugBank: Guar gum (DB13446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guar gum (5 g/l solution in water)
Trial: 27163499
Drug: Ritobegron (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritobegron (20 mg) alone
Trial: 27163499
Drug: Ritobegron (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritobegron (20 mg) with probenecid
Trial: 22922564
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) 3.0 g/day
Trial: 22922564
Drug: Intravenous cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cyclophosphamide (IVC) 0.5‐1.0 g/m(2)/month
Trial: 22922564
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) 1.0 g twice daily
Trial: 22922564
Drug: Oral azathioprine
RxNorm normalized name: Azathioprine
DrugBank: Azathioprine (DB00993)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral azathioprine (AZA) 2 mg/kg/day
Trial: 9779768
Drug: Azithromycin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (500 mg once)
Trial: 9779768
Drug: Rifampin (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampin (600 mg twice daily for four doses)
Trial: 7813328
Drug: Heparin followed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin followed by oral anticoagulants
Trial: 7412801
Drug: Thrombolytic agents
RxNorm normalized name: thrombocytin
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic agents (urokinase or streptokinase followed by heparin and then by oral anticoagulants)
Trial: 27518486
Drug: Sebacoyl dinalbuphine
RxNorm normalized name: Dinalbuphine sebacate
DrugBank: Dinalbuphine sebacate (DB15341)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sebacoyl dinalbuphine ester (SDE) injection (150 mg/2 mL)
Trial: 18156032
Drug: Mechanical bowel
RxNorm normalized name: ascorbic acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mechanical bowel preparation (fluid diet and either polyethylene glycol or sodium phosphate)
Trial: 18156032
Drug: No mechanical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No mechanical bowel preparation (normal meal the day before surgery)
Trial: 23390831
Drug: No mechanical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No mechanical bowel preparation
Trial: 9731794
Drug: FUT-175 (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FUT-175 (2 mg/kg per hour) during cardiopulmonary bypass (group F)
Trial: 9731794
Drug: Coincubation with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coincubation with anti-interleukin-6 monoclonal antibody
Trial: 7800195
Drug: Ketoprofen lysine
RxNorm normalized name: ketoprofen lysine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen lysine salt (80 mg granular sachet)
Trial: 2897812
Drug: Bevantolol (100-300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevantolol (100-300 mg bid)
Trial: 2897812
Drug: Propranolol (80-240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (80-240 mg bid)
Trial: 2897812
Drug: Hydrochlorothiazide (25-50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (25-50 mg bid)
Trial: 2897812
Drug: Both beta‐adrenoceptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both beta‐adrenoceptor antagonists
Trial: 31286802
Drug: Avelumab (anti-PD-L1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Avelumab (anti-PD-L1 antibody)
Trial: 31286802
Drug: Avelumab (as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Avelumab (as second-line treatment)
Trial: 31286802
Drug: Avelumab (as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Avelumab (as maintenance therapy)
Trial: 31286802
Drug: Avelumab (in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Avelumab (in combination with chemotherapy)
Trial: 28332720
Drug: Luliconazole 5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Luliconazole 5% nail solution, applied once daily for 48 weeks
Trial: 28332720
Drug: Vehicle, applied
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle, applied once daily for 48 weeks
Trial: 26469083
Drug: Weight-based RBV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight-based RBV (1,000 or 1,200 mg/day)
Trial: 26469083
Drug: Flat-dose RBV
RxNorm normalized name: RBV
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Flat-dose RBV (800 mg/day)
Trial: 26469083
Drug: Weight-based RBV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight-based RBV (≥13 mg/kg/day)
Trial: 26469083
Drug: Weight-based RBV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight-based RBV (<13 mg/kg/day)
Trial: 17453398
Drug: Indomethacin 3
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indomethacin 3 times daily for 7 days
Trial: 17453398
Drug: Rofecoxib twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib twice daily for 7 days
Trial: 17453398
Drug: Placebo daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo daily for 7 days
Trial: 12967321
Drug: Statin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapy (combined pravastatin and simvastatin)
Trial: 11523255
Drug: Leflunomide (LEF)
RxNorm normalized name: Leflunomide
DrugBank: Leflunomide (DB01097)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Leflunomide (LEF) 20 mg per day
Trial: 11523255
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) 15 mg per week
Trial: 3069466
Drug: Labetalol (200-400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Labetalol (200-400 mg twice daily)
Trial: 3069466
Drug: Nifedipine (10-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (10-20 mg three times daily)
Trial: 26324401
Drug: Glycopyrronium bromide
RxNorm normalized name: Glycopyrronium bromide
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Glycopyrronium bromide 50 µg once daily
Trial: 20524910
Drug: Tiotropium bromide
RxNorm normalized name: Tiotropium Bromide
DrugBank: Tiotropium (DB01409)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tiotropium bromide 18 µg once daily
Trial: 24036725
Drug: Mg ion‐incorporated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mg ion‐incorporated titanium implants
Trial: 24036725
Drug: RBM surface
RxNorm normalized name: hepatitis B surface antigen vaccine Injection [Recombivax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBM surface titanium implants
Trial: 17961107
Drug: HAART regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HAART regimen with four-drug, three-class regimens
Trial: 15047441
Drug: Antenatal gymnastics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antenatal gymnastics (twice a week, 45 min sessions, 60% of maximum heart frequency)
Trial: 7622826
Drug: Fluvoxamine (100‐300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvoxamine (100‐300 mg/day)
Trial: 1814841
Drug: Ofloxacin 100
RxNorm normalized name: ofloxacin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin 100 mg
Trial: 30255188
Drug: Coloured rice
RxNorm normalized name: Rice
DrugBank: Rice (DB10563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coloured rice polyphenol extracts (PE) from purple rice at 10, 20, 50, 100, 200 and 500 μg mL‐1
Trial: 30255188
Drug: Coloured rice
RxNorm normalized name: Rice
DrugBank: Rice (DB10563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coloured rice polyphenol extracts (PE) from red rice at 10, 20, 50, 100, 200 and 500 μg mL‐1
Trial: 30255188
Drug: Coloured rice
RxNorm normalized name: Rice
DrugBank: Rice (DB10563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coloured rice polyphenol extracts (PE) from brown rice at 10, 20, 50, 100, 200 and 500 μg mL‐1
Trial: 30255188
Drug: Brown rice
RxNorm normalized name: Brown rice
DrugBank: Rice (DB10563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brown rice PE at 50 μg mL‐1
Trial: 30255188
Drug: Red rice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red rice PE at 50 μg mL‐1
Trial: 30255188
Drug: Purple rice
RxNorm normalized name: Rice
DrugBank: Rice (DB10563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purple rice PE at 50 μg mL‐1
Trial: 27521719
Drug: 12 SQ
RxNorm normalized name: ODACTRA 12 SQ-HDM Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 SQ HDM SLIT-tablet
Trial: 24798210
Drug: West Wales
RxNorm normalized name: West Dip
FDA approved: no
EMA approved: no
PMDA approved: no
Description: West Wales ADR Profile for Respiratory Medicine
Trial: 20169656
Drug: Optimal treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimal treatment including endoscopic haemostatic and high-dose intravenous proton-pump inhibitors
Trial: 18571502
Drug: Fluvastatin (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin (80 mg/day)
Trial: 12367547
Drug: EMLA (topical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EMLA (topical anaesthetic)
Trial: 26970946
Drug: Therapeutic hypothermia
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic hypothermia treatment
Trial: 26970946
Drug: No therapeutic
RxNorm normalized name: Gel, Multi Ingredient Topical application Gel/Jelly [AVEENO THERAPEUTIC SHAVE GEL]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No therapeutic hypothermia treatment (control)
Trial: 25252624
Drug: TNFα G‐A‐G
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TNFα G‐A‐G haplotype
Trial: 9141257
Drug: Paracetamol 15
RxNorm normalized name: Paracetamol 150 mg and sodium salicylate 100 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol 15 mg/kg
Trial: 16330788
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy plus 5 to 7 plasma exchanges of 50 mL per kg of body weight of 5% human serum albumin for 10 days
Trial: 11974556
Drug: 1 mg/day
RxNorm normalized name: Lyllana 0.1 MG/Day Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/day 17 beta-estradiol combined with 5 or 10 mg/day dydrogesterone
Trial: 11974556
Drug: 2 mg/day
RxNorm normalized name: Neupro 2 MG/Day 24 HR Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg/day 17 beta-estradiol combined with 10 or 20 mg/day dydrogesterone
Trial: 11974556
Drug: 1 mg/day
RxNorm normalized name: Lyllana 0.1 MG/Day Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/day 17 beta-estradiol
Trial: 11974556
Drug: Higher doses
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher doses of dydrogesterone
Trial: 11974556
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (irrespective of estradiol or dydrogesterone dose)
Trial: 9952150
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine 0.075 mg
Trial: 9952150
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine (various doses)
Trial: 9952150
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (0.0 mg intrathecal morphine)
Trial: 9952150
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine (0.0-0.5 mg)
Trial: 24965218
Drug: Oral hygiene
RxNorm normalized name: HYDROGEN PEROXIDE 2.94 mL in 2.94 mL ORAL SPRAY [OROXID Forte Oral Hygiene]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral hygiene instructions (OHI)
Trial: 28646901
Drug: Ezetimibe add-on
RxNorm normalized name: Ezetimibe
DrugBank: Ezetimibe (DB00973)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ezetimibe add-on therapy (10 mg)
Trial: 31409915
Drug: Double-dose statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-dose statin therapy
Trial: 23292315
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D insufficient (serum 25(OH)D ≤32 ng/mL)
Trial: 23292315
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D sufficient (serum 25(OH)D >32 ng/mL)
Trial: 19672935
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (400 microg daily)
Trial: 19672935
Drug: 5-MTHF (daily)
RxNorm normalized name: (6S)-5-MTHF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-MTHF (daily)
Trial: 15047680
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (515 mg/day)
Trial: 15047680
Drug: Antioxidant mixture
RxNorm normalized name: brown mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant mixture (515 mg vitamin C, 371 mg alpha-tocopherol, 171 mg gamma-tocopherol, 252 mg mixed tocotrienols, and 95 mg alpha-lipoic acid)
Trial: 12228852
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil (angiotensin receptor blocker)
Trial: 2873760
Drug: Atracurium, 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium, 0.5 mg/kg
Trial: 8135388
Drug: Pancuronium, 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pancuronium, 0.1 mg/kg
Trial: 2800992
Drug: Indomethacin, 0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin, 0.8 mg/kg i.v. preoperatively, followed by 100 mg rectally 8-hourly for 3 days
Trial: 29551350
Drug: Clotrimazole 1%
RxNorm normalized name: CLOTRIMAZOLE 1% LOTION
DrugBank: Clotrimazole (DB00257)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clotrimazole 1% solution
Trial: 578400
Drug: Haloprogin 1%
RxNorm normalized name: HALOPROGIN 1% CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloprogin 1% solution
Trial: 22480102
Drug: Supportive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive therapy only (Control)
Trial: 9272427
Drug: Continuous HRT
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous HRT (25 or 50 micrograms/day of transdermal 17 beta‐estradiol plus medrogestone 5 mg/day for 12 days/month)
Trial: 9272427
Drug: Ipriflavone 600
RxNorm normalized name: IPRIFLAVONE
DrugBank: Ipriflavone (DB13618)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ipriflavone 600 mg/day plus 17 beta‐estradiol 25 micrograms/day plus medrogestone 5 mg/day for 12 days/month
Trial: 9272427
Drug: Calcium 500
RxNorm normalized name: Calcium 500+D
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium 500 mg/day (control group)
Trial: 9272427
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose HRT (not specified)
Trial: 21424975
Drug: Normobaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normobaric oxygen therapy
Trial: 11810122
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of normobaric plus hyperbaric oxygen therapy
Trial: 29131090
Drug: Active control
RxNorm normalized name: Accu-Chek Active Control Solution
DrugBank: Pyrithione (DB06815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active control group (weekly online information on depression)
Trial: 21812890
Drug: Premeal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Premeal insulin glulisine
Trial: 21812890
Drug: Postmeal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postmeal insulin glulisine
Trial: 17468795
Drug: New sling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New sling exercise therapy with home training
Trial: 17468795
Drug: New sling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New sling exercise therapy without home training
Trial: 10770746
Drug: Subunit vaccine
RxNorm normalized name: covid-19, protein subunit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subunit vaccine
Trial: 31744798
Drug: LOADING group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LOADING group (3 monthly injections followed by as needed)
Trial: 21277674
Drug: EE 20
RxNorm normalized name: AcidFree 200mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EE 20 μg/drsp 3mg in a 24/4 regimen for 7 or 13 cycles